Home |
Free Dividend Report |
Stock Splits Calendar |
WINT Stock Split History |
Preferred Stock Newsletter |
WINT Options Chain |
Stock Message Boards |
Windtree Therapeutics (WINT) has 2 splits in our WINT split history database. The first split for WINT took place on February 24, 2023. This was a 1 for 50 reverse split, meaning for each 50 shares of WINT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split. WINT's second split took place on April 22, 2024. This was a 1 for 18 reverse split, meaning for each 18 shares of WINT owned pre-split, the shareholder now owned 1 share. For example, a 20 share position pre-split, became a 1.11111111111111 share position following the split.
When a company such as Windtree Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the WINT split history from start to finish, an original position size of 1000 shares would have turned into 1.11111111111111 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Windtree Therapeutics shares, starting with a $10,000 purchase of WINT, presented on a split-history-adjusted basis factoring in the complete WINT split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $1,584.00 | |
End price/share: | $5.07 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.68% | |
Average Annual Total Return: | -43.71% | |
Starting investment: | $10,000.00 | |
Ending investment: | $31.99 | |
Years: | 10.00 |
About Windtree Therapeutics |
Windtree Therapeutics is a biopharmaceutical company focused on the development of therapeutics. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. Co.'s heart failure cardiovascular portfolio also includes sarco endoplasmic reticulum Ca2+ -ATPase 2a (SERCA2a) activators. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds. In addition, Co.'s cardiovascular drug product candidates include rostafuroxin, a product candidate for the treatment of hypertension in patients with a specific genetic profile. According to our WINT split history records, Windtree Therapeutics has had 2 splits. |
WINT Split History Table | |
Date | Ratio |
02/24/2023 | 1 for 50 |
04/22/2024 | 1 for 18 |
Healthcare Stock Splits |
WINT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
WOOF Split History
Free WINT Email Alerts:
|
WINT Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.